{"id":"W3038822856","doi":"10.1016/j.clml.2020.06.024","title":"Feasibility of Long-term Proteasome Inhibition in Multiple Myeloma by in-class Transition From Bortezomib to Ixazomib","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Takeda Canada; Takeda Oncology; Amgen; Takeda Pharmaceuticals U.S.A.; British Microcirculation Society; Celgene","keywords":"Medicine; Bortezomib; Ixazomib; Internal medicine; Regimen; Multiple myeloma; Proteasome inhibitor; Clinical endpoint; Oncology; Surgery; Randomized controlled trial; Carfilzomib","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007685833,0.000501397,0.001496266,0.0002495791,0.00006715645,0.00003743769,0.000247011,0.0005734831,0.0002127791],"category_scores_gemma":[0.002317345,0.0004772363,0.0004434192,0.0009513091,0.0003241846,0.0002955583,0.000164695,0.0005549465,0.0002467288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001625017,"about_ca_system_score_gemma":0.0009491781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001026912,"about_ca_topic_score_gemma":0.0006718417,"domain_scores_codex":[0.9942393,0.0005580034,0.00212776,0.001400169,0.0008446649,0.0008301359],"domain_scores_gemma":[0.9966769,0.0008137942,0.0002954727,0.0007735466,0.0002018755,0.001238417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01129243,0.001637611,0.780507,0.0002485751,0.0001141218,0.001482891,0.0005399428,0.00001698703,0.0234568,0.000007070144,0.0005256424,0.1801709],"study_design_scores_gemma":[0.02564161,0.001459438,0.951283,0.0005903174,0.00006360823,0.00002167037,0.00008396863,0.002737647,0.01756351,0.00009072309,0.00009663466,0.0003678968],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919617,0.0002221813,0.0003127967,0.003068636,0.0001304777,0.003580266,0.0003847747,0.0001098163,0.0002293057],"genre_scores_gemma":[0.9957329,0.00008331463,0.0008885265,0.001643603,0.0002796225,0.0002855518,0.0009686571,0.00007372435,0.00004408705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.179803,"threshold_uncertainty_score":0.999768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07255064007328885,"score_gpt":0.3545877338522112,"score_spread":0.2820370937789224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}